Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
作者信息
Paul Elisabeth, Brown Garrett W, Kalk Andreas, Ridde Valéry
机构信息
Université libre de Bruxelles, School of Public Health, Campus Erasme, Route de Lennik 808, CP 591, 1070 Brussels, Belgium.
University of Leeds, Global Health Theme, POLIS, Leeds, United Kingdom.
出版信息
Vaccine. 2021 Aug 16;39(35):4921-4924. doi: 10.1016/j.vaccine.2021.07.045. Epub 2021 Jul 20.
Abstract
摘要
相似文献
1
Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
Vaccine. 2021 Aug 16;39(35):4921-4924. doi: 10.1016/j.vaccine.2021.07.045. Epub 2021 Jul 20.
2
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
3
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.
Viruses. 2023 Oct 30;15(11):2181. doi: 10.3390/v15112181.
4
Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID-19 in the UAE.
BMC Public Health. 2021 Aug 30;21(1):1602. doi: 10.1186/s12889-021-11620-z.
5
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
6
Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
BMJ Open. 2022 Jan 3;12(1):e057127. doi: 10.1136/bmjopen-2021-057127.
7
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study.
J Immunol Methods. 2024 May;528:113665. doi: 10.1016/j.jim.2024.113665. Epub 2024 Mar 14.
8
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17.
9
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.
Microbiol Spectr. 2021 Sep 3;9(1):e0034121. doi: 10.1128/Spectrum.00341-21. Epub 2021 Aug 4.
10
Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants.
Expert Rev Vaccines. 2022 Jan;21(1):47-67. doi: 10.1080/14760584.2022.1997601. Epub 2022 Jan 11.
引用本文的文献
1
The devil's in the detail: an appraisal of the use of innovative financing mechanisms for pandemic prevention, preparedness and response.
Global Health. 2025 Mar 27;21(1):13. doi: 10.1186/s12992-025-01103-w.
2
High coverage and equitable distribution of COVID-19 vaccine uptake in two vulnerable areas in Bangladesh.
PLOS Glob Public Health. 2025 Jan 17;5(1):e0004178. doi: 10.1371/journal.pgph.0004178. eCollection 2025.
3
Who is "anti-science"?
Public Health Pract (Oxf). 2024 Mar 29;7:100493. doi: 10.1016/j.puhip.2024.100493. eCollection 2024 Jun.
4
Surfing Corona waves - instead of breaking them: Rethinking the role of natural immunity in COVID-19 policy.
F1000Res. 2023 Aug 24;11:337. doi: 10.12688/f1000research.110593.2. eCollection 2022.
5
Public Health Management of the COVID-19 Pandemic in Australia: The Role of the Morrison Government.
Int J Environ Res Public Health. 2022 Aug 20;19(16):10400. doi: 10.3390/ijerph191610400.
6
Conditionality of COVID-19 vaccine acceptance in European countries.
Vaccine. 2022 Feb 23;40(9):1191-1197. doi: 10.1016/j.vaccine.2022.01.054. Epub 2022 Feb 1.
7
COVID-19: an 'extraterrestrial' disease?
Int J Infect Dis. 2021 Sep;110:155-159. doi: 10.1016/j.ijid.2021.07.051. Epub 2021 Jul 26.
本文引用的文献
1
What does a pandemic proof health system look like?
Glob Health Action. 2021 Jan 1;14(1):1927315. doi: 10.1080/16549716.2021.1927315.
2
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
Open Forum Infect Dis. 2021 Jul 6;8(11):ofab358. doi: 10.1093/ofid/ofab358. eCollection 2021 Nov.
3
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
N Engl J Med. 2021 Sep 2;385(10):875-884. doi: 10.1056/NEJMoa2107715. Epub 2021 Jul 7.
4
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
JAMA. 2021 Aug 10;326(6):499-518. doi: 10.1001/jama.2021.11330.
5
When the worldwide response to the COVID-19 pandemic is done without health promotion.
Glob Health Promot. 2021 Jun;28(2):3-6. doi: 10.1177/17579759211015129. Epub 2021 Jun 12.
6
Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
JAMA Netw Open. 2021 Jun 1;4(6):e2111788. doi: 10.1001/jamanetworkopen.2021.11788.
7
Six months of COVID vaccines: what 1.7 billion doses have taught scientists.
Nature. 2021 Jun;594(7862):164-167. doi: 10.1038/d41586-021-01505-x.
8
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
JAMA. 2021 Jul 6;326(1):35-45. doi: 10.1001/jama.2021.8565.
9
BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease Severity.
Clin Infect Dis. 2022 Feb 11;74(3):517-520. doi: 10.1093/cid/ciab446.
10
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
Zotero 插件